Redeye has updated its estimates for Carasent following the Q2 2024 report, which was quite undramat...
- Q2e: lower top-line y-o-y, but strong GM supports EBIT - EBIT down 5-4% on slower assumed market r...
Ahead of the Fiskars Q2, due on 18 July, we maintain our estimates intact.
- Q2e: Slight margin improvements expected - Org. estimates mostly unchanged, EBITA down 2-3% on FX ...
Redeye updates its estimates and valuation following Vitec releasing its Q2 2024 report.
Redeye updates its estimates and valuation following Lifco releasing its Q2 2024 report.
Atria raised its guidance on 12 July. The company now expects its adjusted EBIT to improve from 2023...
Redeye takes a positive stance towards Fortnox following an overall solid Q2 report, with strong gro...
- Q2 sales SEK 54m, EBIT SEK -1.0m, vs. ABGSCe 52m and -1.
Atria raised its adjusted EBIT guidance and now expects growing earnings in 2024 (earlier: adjusted ...
Redeye sees a Q2 report coming in below our expectations on margins and EBITA, as all three Division...
- Adj. EBITA of SEK 161m (0% vs ABGSC, -3% vs cons) - Est's down 2-3% on lower effects of cost savin...
Redeye comments on Climeon’s Q2 figures being without any material income in the quarter, which was ...
Redeye provides its initial take on Vitec’s Q2 2024 report, which mostly exceeded our estimates.
Redeye sees an overall solid report, with the rebound in ACV being the highlight.
